In type 1 diabetes, at doses of 0.2 to 0.4 units/kg, insulin detemir exerts more than 50% of its maximum effect from 3 to 4 hours up to approximately 14 hours after dose administration. The time-action profile of detemir is lessvariable than NPH, but varies with dose.Created: June...
Human Insulins Human insulinwas the first medication to be commercially manufactured usingrecombinant DNAtechnology.60Currently available human insulins include short-, intermediate-, and long-acting preparations. Each preparation has advantages and disadvantages, which will be considered in turn. ...
Long-acting Premixed Human Insulin Biologics Short-acting Intermediate-acting Premixed By Brand Insulin Analogs and Biosimilars Lantus NovoRapid/Novolog Humalog Other Brands Human Insulin Biologics Actrapid, Insulatard, and Mixtard Humulin Insuman By Product Type Pens Reusable Disposable Pen Needles...
;long-acting —insulina de acción prolongada;NPH —insulina NPH;pre-mixed —insulina premezclada;rapid-acting —insulina de acción rápida;rapid-acting — analogueanálogo de insulina de acción rápida;recombinant —insulina recombinante;regular —insulina regular;to take —inyectarse insulina...
This medication is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). Insulin Regular Human is available under the following different brand names: Humulin R, Novolin R, Humulin...
;long-acting —insulina de acción prolongada;NPH —insulina NPH;pre-mixed —insulina premezclada;rapid-acting —insulina de acción rápida;rapid-acting — analogueanálogo de insulina de acción rápida;recombinant —insulina recombinante;regular —insulina regular;to take —inyectarse insulina...
For people with diabetes, maintaining blood glucose levels within the nondiabetic range is effective in delaying or even preventing long-term complications, but achieving near normoglycemia is still challenging for these patients. This is due to the fact that the current fast-acting insulin, ...
Long-acting insulin analogs versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;(2):CD005613.PubMedGoogle Scholar 9. Lipska KJ, Hirsch IB, Riddle MC. Human insulin for type 2 diabetes: an effective, less-expensive option. JAMA. ...
To study the pharmacokinetic and pharmacodynamic profile of insulin aspart (a new fast-acting human insulin analog) after subcutaneous administration in the deltoid, abdominal, and thigh sites and to compare this profile with regular human insulin (Novolin; Novo Nordisk A/S, Copenhagen).A total of...
Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults J Clin Endocrinol Metab, 86 (3) (2001), pp....